Market Closed -
Irish S.E.
11:55:00 2024-05-14 am EDT
|
5-day change
|
1st Jan Change
|
2.6
EUR
|
0.00%
|
|
-0.38%
|
-3.70%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
333.1
|
649.8
|
1,365
|
846.3
|
737.1
|
709.8
|
-
|
-
|
Enterprise Value (EV)
1 |
399.4
|
804.7
|
1,532
|
1,058
|
737.1
|
945.1
|
961.8
|
961.7
|
P/E ratio
|
15.8
x
|
22.5
x
|
28.1
x
|
18.6
x
|
16.5
x
|
13.5
x
|
12.4
x
|
10.5
x
|
Yield
|
0.6%
|
0.65%
|
0.33%
|
0.55%
|
-
|
0.75%
|
0.78%
|
0.84%
|
Capitalization / Revenue
|
0.2
x
|
0.36
x
|
0.7
x
|
0.41
x
|
0.29
x
|
0.27
x
|
0.25
x
|
0.24
x
|
EV / Revenue
|
0.24
x
|
0.44
x
|
0.79
x
|
0.51
x
|
0.29
x
|
0.35
x
|
0.34
x
|
0.33
x
|
EV / EBITDA
|
6.82
x
|
12.1
x
|
17.7
x
|
10.8
x
|
6.36
x
|
7.8
x
|
7.44
x
|
6.94
x
|
EV / FCF
|
3.94
x
|
0.02
x
|
36.8
x
|
15.4
x
|
-
|
51.5
x
|
15
x
|
16.7
x
|
FCF Yield
|
25.4%
|
6,293%
|
2.72%
|
6.51%
|
-
|
1.94%
|
6.65%
|
5.98%
|
Price to Book
|
1.24
x
|
3.21
x
|
5.43
x
|
2.92
x
|
-
|
2.03
x
|
1.95
x
|
2.18
x
|
Nbr of stocks (in thousands)
|
273,015
|
273,015
|
273,015
|
273,015
|
273,015
|
273,015
|
-
|
-
|
Reference price
2 |
1.220
|
2.380
|
5.000
|
3.100
|
2.700
|
2.600
|
2.600
|
2.600
|
Announcement Date
|
3/27/20
|
3/2/21
|
3/1/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,665
|
1,824
|
1,943
|
2,071
|
2,553
|
2,672
|
2,802
|
2,937
|
EBITDA
1 |
58.56
|
66.71
|
86.48
|
98.04
|
116
|
121.2
|
129.4
|
138.6
|
EBIT
1 |
40.25
|
46.72
|
59.55
|
69.57
|
77.76
|
86.17
|
93.16
|
103.1
|
Operating Margin
|
2.42%
|
2.56%
|
3.06%
|
3.36%
|
3.05%
|
3.22%
|
3.32%
|
3.51%
|
Earnings before Tax (EBT)
1 |
26.46
|
33.53
|
55.8
|
54.68
|
52.9
|
59.13
|
65.88
|
75.24
|
Net income
1 |
21.03
|
27.83
|
48.08
|
45.59
|
44.82
|
47.28
|
52.13
|
52.71
|
Net margin
|
1.26%
|
1.53%
|
2.47%
|
2.2%
|
1.76%
|
1.77%
|
1.86%
|
1.79%
|
EPS
2 |
0.0770
|
0.1060
|
0.1780
|
0.1670
|
0.1640
|
0.1924
|
0.2098
|
0.2482
|
Free Cash Flow
1 |
101.4
|
50,640
|
41.65
|
68.88
|
-
|
18.35
|
64
|
57.5
|
FCF margin
|
6.09%
|
2,776.54%
|
2.14%
|
3.33%
|
-
|
0.69%
|
2.28%
|
1.96%
|
FCF Conversion (EBITDA)
|
173.19%
|
75,907.24%
|
48.16%
|
70.25%
|
-
|
15.14%
|
49.47%
|
41.49%
|
FCF Conversion (Net income)
|
482.32%
|
181,981.53%
|
86.64%
|
151.08%
|
-
|
38.81%
|
122.77%
|
109.09%
|
Dividend per Share
2 |
0.007300
|
0.0154
|
0.0166
|
0.0170
|
-
|
0.0194
|
0.0203
|
0.0219
|
Announcement Date
|
3/27/20
|
3/2/21
|
3/1/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
991.8
|
-
|
-
|
-
|
1,290
|
1,374
|
EBITDA
1 |
-
|
-
|
51.13
|
64.86
|
54
|
70
|
EBIT
1 |
-
|
-
|
34.07
|
43.69
|
38
|
53
|
Operating Margin
|
-
|
-
|
-
|
-
|
2.95%
|
3.86%
|
Earnings before Tax (EBT)
1 |
20.34
|
-
|
18.39
|
34.51
|
24
|
40
|
Net income
1 |
16.06
|
-
|
-
|
29.8
|
20
|
33
|
Net margin
|
1.62%
|
-
|
-
|
-
|
1.55%
|
2.4%
|
EPS
2 |
0.0590
|
-
|
0.0550
|
0.1090
|
0.0720
|
0.1200
|
Dividend per Share
2 |
0.006100
|
0.0110
|
0.006400
|
-
|
0.007000
|
0.0120
|
Announcement Date
|
8/30/22
|
2/28/23
|
9/14/23
|
2/27/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
66.4
|
155
|
167
|
211
|
-
|
235
|
252
|
252
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.133
x
|
2.323
x
|
1.935
x
|
2.157
x
|
-
|
1.941
x
|
1.948
x
|
1.817
x
|
Free Cash Flow
1 |
101
|
50,640
|
41.7
|
68.9
|
-
|
18.4
|
64
|
57.5
|
ROE (net income / shareholders' equity)
|
23.3%
|
14.5%
|
21.2%
|
18.5%
|
-
|
13.7%
|
13.3%
|
12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
3.07%
|
3.38%
|
3.71%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
1,538
|
1,540
|
1,421
|
Book Value Per Share
2 |
0.9900
|
0.7400
|
0.9200
|
1.060
|
-
|
1.280
|
1.330
|
1.190
|
Cash Flow per Share
2 |
0.2100
|
0.2500
|
0.1900
|
0.3000
|
-
|
0.1800
|
0.2600
|
0.2900
|
Capex
1 |
5.59
|
15.7
|
10.5
|
14
|
-
|
49.9
|
54.6
|
33.6
|
Capex / Sales
|
0.34%
|
0.86%
|
0.54%
|
0.67%
|
-
|
1.87%
|
1.95%
|
1.14%
|
Announcement Date
|
3/27/20
|
3/2/21
|
3/1/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Average target price
4.42
EUR Spread / Average Target +70.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.70% | 766M | | +19.14% | 72.09B | | -3.34% | 23.88B | | +10.27% | 8.89B | | +12.67% | 8.46B | | -17.41% | 8.29B | | +9.65% | 4.9B | | +21.40% | 4.34B | | -1.41% | 3.98B | | -1.99% | 3.89B |
Pharmaceuticals Wholesale
|